Company intelligence / Profile preview

PIUR Imaging

Vienna, Austria

Ownership: Private
Development stage: Other

Overview

PIUR Imaging has achieved FDA clearance and is actively commercializing its tomographic 3D ultrasound technology. The company's solution reduces user-dependency by 80% and enables automated volume measurements and reporting. Clinical applications focus primarily on thyroid diagnostics with automated ACR TI-RADS reporting.

Therapeutic areas: EndocrinologyCardiovascularNeurologyDermatologyRheumatology
Modalities: Device
Industry: Medical Imaging

Partnerships

FUJIFILM VisualSonics (partnership for ultra-high-frequency 3D ultrasound)GE HealthCare (integration partnership for LOGIQ scanners)

Beyond the preview

Go deeper on PIUR Imaging.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PIUR Imaging.

Explore the full profile